This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Years of investment in digital, cloud and security strategy has helped Accenture evolve as a trusted and viable consulting services provider. It is currently the world’s top consultancy firm by revenues that increased 5% in 2019 with a contribution of 56% from consulting services.
Accenture (ACN) to Gain From Avieco Acquisition: Here's How
by Zacks Equity Research
The acquisition is expected to boost Accenture's (ACN) ESG measurement, as well as its analytics and sustainability capabilities in the U.K.
Accenture (ACN) Set to Invest in Titan Space Technologies
by Zacks Equity Research
Titan is now a participant in Accenture (ACN) Ventures' Project Spotlight.
The Zacks Analyst Blog Highlights Verizon, Accenture, United Parcel Service, AT&T, and Booking Holdings
by Zacks Equity Research
Verizon, Accenture, United Parcel Service, AT&T, and Booking Holdings are part of the Analyst Blog.
Accenture (ACN) Joins Health Data Collaborative, AI4BetterHearts
by Zacks Equity Research
Accenture's (ACN) goal behind joining the collaborative is to support and advance cardiovascular disease prevention through integrating innovation and emerging technologies.
Here's How Much a $1000 Investment in Accenture Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Top Analyst Reports for Verizon, Accenture, UPS & Others
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications Inc. (VZ), Accenture plc (ACN), and United Parcel Service, Inc. (UPS).
HCKT vs. ACN: Which Stock Is the Better Value Option?
by Zacks Equity Research
HCKT vs. ACN: Which Stock Is the Better Value Option?
How Accenture (ACN) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Accenture (ACN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Accenture (ACN) Q2 Earnings, Revenues Top Estimates, View Up
by Zacks Equity Research
Accenture's (ACN) second-quarter fiscal 2022 earnings benefit from higher revenues and operating results, lower non-operating expenses.
Accenture (ACN) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Accenture (ACN) delivered earnings and revenue surprises of 7.63% and 2.69%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?
Accenture (ACN) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Accenture (ACN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Reasons to Add Maximus (MMS) Stock to Your Portfolio Now
by Zacks Equity Research
With more than 40 years of experience, Maximus has grown to be a leading operator of government health and human services programs globally.
Should iShares MSCI USA Min Vol Factor ETF (USMV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for USMV
What's in the Cards for Accenture (ACN) in Q2 Earnings?
by Zacks Equity Research
Accenture's (ACN) second-quarter fiscal 2022 earnings and revenues are expected to have improved year over year.
Affirm (AFRM) Down 15% Despite Raising Guidance: Here's Why
by Zacks Equity Research
Affirm Holdings (AFRM) boosts fiscal 2022 revenue less transaction costs' guidance to at least $600 million from the previous range of $585-$595 million.
US Stock Market Consolidates Ahead Of The Fed's Pivotal Liftoff Meeting
by Daniel Laboe
Get ready for what promises to be one of the most important weeks of market-moving action as investors' focus shifts towards the Federal Reserve
Global Payments (GPN): Story of an Undervalued Cashflow Beast
by Zacks Equity Research
Global Payments (GPN) enhances its share buyback program by increasing the available fund to $2 billion.
Accenture (ACN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Accenture (ACN) closed at $311.58 in the latest trading session, marking a +0.67% move from the prior day.
6 Reasons to Add Robert Half (RHI) Stock to Your Portfolio Now
by Zacks Equity Research
Robert Half's (RHI) wholly-owned subsidiary, Protiviti, is strongly positioned in the market, and is also a solid revenue performer.
Reasons to Retain FactSet (FDS) Stock in Your Portfolio
by Zacks Equity Research
The recent acquisition of Cobalt Software is expected to enhance FactSet's (FDS) data and workflow solutions, and expand its private markets offering.
5 Reasons to Add ABM Industries (ABM) Stock to Your Portfolio
by Zacks Equity Research
The acquisition of Able Services is expected to strengthen ABM Industries' engineering and technical services, and expand its sustainability and energy efficiency offerings.
Information Services Group (III) Meets Q4 Earnings Estimates
by Zacks Equity Research
ISG (III) delivered earnings and revenue surprises of 0% and 2.35%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Accenture (ACN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Accenture (ACN) closed at $309.52, marking a +0.03% move from the previous day.
The Zacks Analyst Blog Highlights UnitedHealth Group, Accenture, Union Pacific, The Boeing Company and Prologis
by Zacks Equity Research
UnitedHealth Group, Accenture, Union Pacific, The Boeing Company and Prologis are included in this blog.
Reasons to Hold Trane Technologies (TT) in Your Portfolio
by Zacks Equity Research
Trane Technologies (TT) prioritizes improving its business operating system and innovation through transformation initiatives and investments.